Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 2 of 2
Full-Text Articles in Medicine and Health Sciences
Oncolog, Volume 63. Number 03, March 2018, Bryan Tutt
Oncolog, Volume 63. Number 03, March 2018, Bryan Tutt
OncoLog MD Anderson's Report to Physicians (All issues)
- Local Consolidative Therapy Plus Immunotherapy or Targeted Agents for NSCLC: Clinical trials explore surgery/radiation plus immune checkpoint or tyrosine kinase inhibitors for metastatic non-small cell lung cancer
- INBRIEF: CAR T Cells Elicit Durable Responses in Large B Cell Lymphoma
- Managing Opioid Use in Cancer Patients: Vigilance and interventions ensure patient safety
- Hepatitis C Virus Linked to Head and Neck Cancers: Association of HCV with extrahepatic cancers has implications for HCV testing, treatment
- HOUSE CALL: Understanding cancer Risk and Risk factors-Your risk factors might affect your need for cancer screening
Oncolog, Volume 60, Number 02, February 2015, Sarah Bronson, Bryan Tutt, N. Danckers
Oncolog, Volume 60, Number 02, February 2015, Sarah Bronson, Bryan Tutt, N. Danckers
OncoLog MD Anderson's Report to Physicians (All issues)
- Natural Killer Cell Therapy May Augment Treatment of Hematological Cancers: Tough cancer treatments can severely weaken the body's natural ability to attack cancer cells. To improve immune recovery and function in patients who have undergone these treatments, especially those who may later receive a stem cell transplant, researchers are turning to natural killer cells that have been expanded in the laboratory.
- Concurrent Treatment of HIV and Cancer Improves Survival Outcomes: Concurrent HIV and cancer present special challenges in the clinic, regardless of which disease is diagnosed first. The simultaneous treatment of HIV and cancer is complicated by patients' weakened immune …